Answers are grounded in this paper and cite their sources.
Postmenopausal osteoporosis (PMOP) imposes a significant health burden due to estrogen deficiency-induced bone loss. Auricularia auricula polysaccharide (AAP), a traditional edible fungal component, has shown anti-oxidant and anti-inflammatory properties, yet its potential osteoprotective effects remain insufficiently characterized. Here, ultrasound-assisted enzymatic extraction of AAP was optimized using a Box-Behnken design. Following slight practical adjustment of the response-surface-predicted optimal conditions, the experimental extraction yield of AAP reached 30.15 ± 0.48%. Physicochemical characterization identified AAP as an acidic heteropolysaccharide with molecular weights ranging from 976 to 1.5 × 10 6 Da, enriched in glucose and uronic acid residues. In the ovariectomized (OVX) rat model, high-dose AAP (500 mg/kg) attenuated bone loss under the tested conditions, while no increase in uterine index was observed. Mechanistic studies provided evidence that the IGF-1/IGF-1R signaling axis is involved in AAP-induced osteogenic differentiation, as supported by increased phosphorylation of IGF-1R and its downstream signaling molecules and by IGF-1R knockout experiments. In vitro simulated gastrointestinal digestion further showed that AAP retained measurable osteogenic activity after digestion. These findings support the potential of AAP as a functional food ingredient for supporting bone health.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: